Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 185
1.
World Neurosurg ; 184: 65-73, 2024 Apr.
Article En | MEDLINE | ID: mdl-38218444

BACKGROUND: Spinal phosphaturic mesenchymal tumor (PMT) is a rare disorder but can be cured once the diagnosis is clear and a complete removal by surgery is performed. To the best of our knowledge, only 22 cases in the spine have been described, and we report a case with the largest number of spinal segments (T12-L5) affected among spine PMT cases. METHODS: A comprehensive literature search was performed until May 23, 2023, following the Preferred Reporting Items for Systematic Reviews guidelines. Studies were chosen through relevant PubMed, Web of Science, and EMBASE searches to prioritize obtaining the largest studies. The Medical Subject Headings and Boolean operators employed for this search were ("PMT" or "TIO" or "Tumor-induced osteomalacia" or "phosphaturic mesenchymal tumor") and ("spine" or "spinal"). Two researchers (L.S.Z. and D.B.C) independently reviewed and evaluated the included articles. Any differing opinions were discussed until a consensus was reached. A total of 18 studies were included. A case report is also presented. RESULTS: We report a case of spinal PMT. The full text of the relevant articles was construed. A total of 18 studies were reviewed and consolidated. These articles are roughly divided into the following 5 subcategories: 1) clinical features and baseline distribution, 2) laboratory and imaging findings, 3) pathological manifestations, and 4) surgical methods and treatment options. CONCLUSIONS: Spinal PMT is very rare with a high rate of misdiagnosis and debilitating complications, so it is of significance to increase awareness of the disease among spine surgeons consulted by patients with spinal PMT. 68Ga-DOTATOC-PET/CT shows very high sensitivity to the spinal PMT but there is no way to exactly determine the location of the tumor. PMT has unique immunohistochemical characteristics and malignant PMT is rare. Once diagnosed, complete surgical excision is the recommended treatment. Burosumab is one of the available options, especially in cases that are recurrent and difficult to surgically resect.


Mesenchymoma , Neoplasms, Connective Tissue , Soft Tissue Neoplasms , Humans , Neoplasms, Connective Tissue/diagnosis , Neoplasms, Connective Tissue/etiology , Neoplasms, Connective Tissue/surgery , Positron Emission Tomography Computed Tomography , Mesenchymoma/diagnosis , Mesenchymoma/diagnostic imaging , Soft Tissue Neoplasms/pathology , Spine/pathology
3.
Zhonghua Bing Li Xue Za Zhi ; 52(1): 25-30, 2023 Jan 08.
Article Zh | MEDLINE | ID: mdl-36617902

Objective: To investigate the clinical, radiological, histological and molecular features and the differential diagnosis of fibrocartilaginous mesenchymoma (FM). Methods: Four cases of FM diagnosed in the Department of Pathology, the Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine from 2020 to 2022 were analyzed. Related literature was also reviewed. Results: Case 1 was a 10-year-old girl with bone destruction in the sacrum and L5 articular processes revealed by CT scan. Case 2 was a 7-year-old girl with an aggressive lesion in her right distal ulna. Case 3 was an 11-year-old boy with a lesion in the metaphysis of his left proximal tibia. Case 4 was an 11-year-old boy with bone destruction in the distal portion of a radius. Microscopically, the four tumors all consisted of numerous spindle cells, hyaline cartilage nodules, and bone trabeculae. The hypocellular to moderately cellular spindle cell component contained elongated cells with slightly hyperchromatic, mildly atypical nuclei arranged in bundles or intersecting fascicles. Benign-appearing cartilaginous nodules of various sizes and shapes were scattered throughout the tumors. There were areas mimicking epiphyseal growth-plate characterized by chondrocytes arranged in parallel columns and areas of enchondral ossification. The stroma was rich in mucus in case 1. Mutation of GNAS and IDH1/IDH2 and amplification of MDM2 gene were not found in any of the three tested cases. Conclusions: FM is very rare and tends to affect young patients. It most frequently occurs in the metaphysis of long tubular bones, followed by the iliac-pubic bones and vertebrae. FM is characterized by a mixed population of spindle cells, hyaline cartilage nodules and trabeculae of bone, without specific immunophenotypes and molecular alternations. As a borderline, locally aggressive neoplasm, surgical removal with a wide margin is generally the treatment of choice for FM.


Mesenchymoma , Humans , Male , Female , Child , Mesenchymoma/diagnostic imaging , Mesenchymoma/surgery , Mesenchymoma/pathology , China , Osteogenesis , Cartilage/pathology , Tomography, X-Ray Computed
6.
Skeletal Radiol ; 52(4): 791-795, 2023 Apr.
Article En | MEDLINE | ID: mdl-36042034

Fibrocartilaginous mesenchymoma (FM) is a rare bone tumor mimicking other fibrocartilaginous lesions on imaging and histologically. Hence, it is difficult to diagnose this entity especially on small biopsies. In this article, we report a case of FM mimicking desmoplastic fibroma on biopsy. A 36-year-old male presented with pain in the left hip. Imaging showed a large expansile lytic lesion involving the acetabulum and pubis. The differential diagnosis was suggestive of giant cell tumor, aneurysmal bone cyst, intraosseous desmoplastic fibroma, and chondrosarcoma. Biopsy revealed a low-grade spindle cell lesion with no evidence of osteoid or chondroid matrix. The lack of cartilaginous nodules in the biopsy prompted a preoperative diagnosis of desmoplastic fibroma. The excised mass showed bland spindle cell proliferation, benign cartilage nodules, and epiphyseal plate-like enchondral ossification suggestive of fibrocartilaginous mesenchymoma. Negative immunostaining for SATB2, CDK4, and MDM2 ruled out low-grade central osteosarcoma. Though GNAS mutations were not performed in this case, rimming of the bony trabeculae at the periphery of the epiphyseal growth plate-like cartilaginous nodule ruled out fibrous dysplasia. The absence of cartilaginous component misleads the diagnosis preoperatively in small biopsies.


Bone Neoplasms , Fibroma, Desmoplastic , Mesenchymoma , Male , Humans , Adult , Mesenchymoma/diagnostic imaging , Mesenchymoma/surgery , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/surgery , Bone and Bones/pathology , Pelvis/pathology
7.
AJNR Am J Neuroradiol ; 43(6): 817-822, 2022 06.
Article En | MEDLINE | ID: mdl-35589138

Phosphaturic mesenchymal tumors (PMTs) are neoplasms associated with tumor-induced osteomalacia. Patients typically present with pathologic fractures in the setting of chronic hypophosphatemic hyperphosphaturic osteomalacia, as well as gradual muscle weakness, bone pain, and difficulty walking. Because of their rarity and nonspecific symptomatology, phosphaturic mesenchymal tumors often go undiagnosed for years. Even when discovered on imaging, the tumors can be diagnostically challenging for radiologists. Phosphaturic mesenchymal tumors often tend to be small and can be located nearly anywhere in the body, and, therefore, can mimic many other tumors. This case highlights the imaging and pathologic markers of a phosphaturic mesenchymal tumor, often found in a patient with tumor-induced osteomalacia.


Mesenchymoma , Neoplasms, Connective Tissue , Osteomalacia , Paraneoplastic Syndromes , Humans , Mesenchymoma/diagnosis , Mesenchymoma/diagnostic imaging , Neoplasms, Connective Tissue/diagnosis , Neoplasms, Connective Tissue/diagnostic imaging , Osteomalacia/diagnostic imaging , Osteomalacia/etiology , Paraneoplastic Syndromes/complications , Paraneoplastic Syndromes/diagnostic imaging
8.
J Foot Ankle Surg ; 61(1): 185-188, 2022.
Article En | MEDLINE | ID: mdl-34384701

We report the case of a phosphaturic mesenchymal tumor of the ankle; an extremely rare lesion that causes osteomalacia via paraneoplastic renal phosphate wasting. A 41-year-old man was referred to plastic surgery with a swelling over the anterior ankle, which had been increasing in size for 1 year. Focused ultrasound assessment was inconclusive, but excision biopsy demonstrated features in keeping with a phosphaturic mesenchymal tumor. Evidence of tumor-induced osteomalacia was subsequently identified on review of historical biochemistry. The patient was followed-up for 1 year with normalization of serum phosphate. In this case report, we present a discussion of the differential diagnosis for foot and ankle soft tissue lesions, and a review of the literature regarding the diagnosis and management of these tumors. Accurate identification of any soft tissue lesion on clinical examination alone is extremely challenging and excision biopsy should be considered in cases of diagnostic uncertainty.


Hypophosphatemia , Mesenchymoma , Neoplasms, Connective Tissue , Osteomalacia , Paraneoplastic Syndromes , Adult , Ankle/diagnostic imaging , Humans , Male , Mesenchymoma/diagnosis , Mesenchymoma/diagnostic imaging , Neoplasms, Connective Tissue/diagnostic imaging , Neoplasms, Connective Tissue/surgery
10.
Radiol Med ; 126(12): 1609-1618, 2021 Dec.
Article En | MEDLINE | ID: mdl-34453276

Phosphaturic mesenchymal tumors (PMTs) are rare mesenchymal neoplasms of soft tissue or bone origin that can give rise to a challenge in diagnostic imaging. These tumors are frequently associated with tumor-induced osteomalacia, also called oncogenic osteomalacia, which is a rare paraneoplastic syndrome characterized by ectopic secretion of fibroblast growth factor 23, a hormone that regulates serum phosphate level. PMTs show polymorphic features on both radiological findings and histological examination, causing problems in diagnosis owing to their similarity with other mesenchymal tumors. Thus, this paper aims to describe radiological aspects of PMTs and suggest an imaging pathway for accurate diagnosis throughout the evidence from the literature review.


Diagnostic Imaging/methods , Mesenchymoma/diagnostic imaging , Osteomalacia/diagnostic imaging , Paraneoplastic Syndromes/diagnostic imaging , Humans , Mesenchymoma/pathology , Osteomalacia/pathology , Paraneoplastic Syndromes/pathology
12.
J Orthop Sci ; 26(5): 870-877, 2021 Sep.
Article En | MEDLINE | ID: mdl-32798110

BACKGROUND: Phosphaturic mesenchymal tumors primarily cause tumor-induced osteomalacia, a rare paraneoplastic syndrome, and half occur in soft tissues. There are few reports about the surgical margins of these tumors. This study aimed to clarify the optimal surgical margin for phosphaturic mesenchymal tumors by analyzing radiological and histopathological features. METHODS: This study included eight cases, seven primary and one recurrent, of tumor-induced osteomalacia caused by soft-tissue phosphaturic mesenchymal tumors that were surgically treated between January 2000 and January 2019. We evaluated the radiological and histopathological features of all tumors and investigated the correlation of these features, the surgical margin, and recurrence of hypophosphatemia. RESULTS: The tumors were located in superficial (n = 5) and deep (n = 3) tissues. Six of the eight tumors had a clear boundary, but five had an irregular margin. Three tumors had a hypointense rim on T2-weighted images, indicating fibrous tumor encapsulation. Histopathological analysis revealed infiltrative growth in six of the eight tumors, which correlated with an irregular margin seen on imaging. Although there was no recurrence in patients treated with an intended wide margin >1 cm, one of the three patients treated with marginal tumor resection experienced a recurrence of hypophosphatemia, with histopathological analysis showing infiltration of subcutaneous fat. In contrast, two tumors with clear boundaries, regular margins, and fibrous capsule seen on imaging, had no infiltrative growth and were cured by marginal resection. In one recurrent case, tumor infiltration was observed in the previous surgical scar, which was not detected on preoperative imaging. CONCLUSIONS: Soft-tissue phosphaturic mesenchymal tumors with an irregular boundary seen on imaging tend to be infiltrative, especially into subcutaneous fat, and should be treated by at least a 1-cm wide margin resection. Tumors with a fibrous capsule with clear and regular margins are cured by marginal margin resection. These findings could inform surgeons' decisions regarding the resection of soft-tissue phosphaturic mesenchymal tumors.


Mesenchymoma , Neoplasms, Connective Tissue , Soft Tissue Neoplasms , Humans , Margins of Excision , Mesenchymoma/diagnostic imaging , Mesenchymoma/surgery , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/surgery , Neoplasms, Connective Tissue/diagnostic imaging , Neoplasms, Connective Tissue/surgery , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/surgery
13.
Clin Hemorheol Microcirc ; 77(1): 61-69, 2021.
Article En | MEDLINE | ID: mdl-32924995

Tumor-induced osteomalacia (TIO) is a vanishingly rare paraneoplastic syndrome which is usually caused by phosphaturic mesenchymal tumors (PMTs). The conventional treatment for PMTs is total resection, and ultrasound-guided radiofrequency ablation (RFA) can also be used for the treatment of PMTs patients, especially for patients in whom complete resection may lead to serious complications. We report two cases with PMT who presented syndrome with progressive musculoskeletal complaints and performed ultrasound-guided biopsy and RFA. Ultrasound-guided RFA, which is a safe and effective minimally invasive treatment option, appears to be a valuable alternative to surgery for patients presenting with PMT. We are the first reported case of RFA guided by ultrasonography in the treatment of PMT.


Catheter Ablation/methods , Image-Guided Biopsy/methods , Mesenchymoma/diagnostic imaging , Osteomalacia/diagnostic imaging , Paraneoplastic Syndromes/diagnostic imaging , Radiofrequency Ablation/methods , Ultrasonography/methods , Adult , Humans , Male , Treatment Outcome , Ultrasonography, Interventional/adverse effects
14.
Int J Oral Maxillofac Surg ; 49(10): 1290-1293, 2020 Oct.
Article En | MEDLINE | ID: mdl-32371177

Ectomesenchymal chondromyxoid tumour (ECT) is an extremely rare intraoral mesenchymal tumour. Most of these tumours have been identified on the anterior aspect of the dorsal surface of the tongue. ECT is difficult to diagnose because of its rarity. We report a case of ECT arising on the lateral border of the tongue in a 67-year-old woman. The tumour, measuring 20 × 10 mm in size, was surgically removed. Histopathologically, the tumour was composed of small polygonal cells arranged in sheets, with a myxoid or hyalinized stroma. The tumour boundary was clear; however, the tumour showed a multinodular structure expanding along the tongue surface without obvious capsule. Careful examination revealed the tumour nodule to be spreading in a skip lesion-like fashion away from the main part of the tumour in the striated muscle layer. Although there was no evidence of recurrence at 18 months after the surgery, our observations suggest that surgery for ECT resection with a safety margin is more appropriate than enucleation.


Mesenchymoma , Myoepithelioma , Tongue Neoplasms , Aged , Female , Humans , Mesenchymoma/diagnostic imaging , Mesenchymoma/surgery , Neoplasm Recurrence, Local , Tongue , Tongue Neoplasms/diagnostic imaging , Tongue Neoplasms/surgery
17.
Clin Nucl Med ; 45(2): e108-e109, 2020 Feb.
Article En | MEDLINE | ID: mdl-31714274

A 50-year-old man with recently diagnosed prostate adenocarcinoma was referred for whole-body Ga-prostate-specific membrane antigen (PSMA) PET/CT scan for staging. Apart from some nonspecific findings, Ga-PSMA PET/CT revealed large soft tissue mass in the left upper abdomen showing heterogeneous tracer uptake. Histological examination of the mass was interpreted as gastrointestinal/extragastrointestinal stromal tumor by pathologists. Prostate-specific membrane antigen is considered specific for prostate cancer cells, although PSMA activity has been described in many other benign or malign conditions. That is why PSMA uptake in uncommon locations for prostate cancer metastasis must be considered for second malignancies or other benign conditions.


Abdomen/diagnostic imaging , Membrane Glycoproteins , Mesenchymoma/diagnostic imaging , Organometallic Compounds , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals , Gallium Isotopes , Gallium Radioisotopes , Humans , Male , Middle Aged
19.
BMJ Case Rep ; 12(10)2019 Oct 25.
Article En | MEDLINE | ID: mdl-31653634

Ectomesenchymal chondromyxoid tumour (ECMT) is a rare benign tumour which classically presents in the anterior tongue. This tumour is grossly under-reported due to lack of immunohistochemical staining in many centres. We report a 46-year-old man who presented with mass in the anterior tongue and was diagnosed with ECMT. Further management of this lesion is explained with a review of the literature.


Chondroma/surgery , Mesenchymoma/surgery , Tongue Neoplasms/surgery , Chondroma/diagnostic imaging , Diagnosis, Differential , Humans , Magnetic Resonance Imaging , Male , Mesenchymoma/diagnostic imaging , Middle Aged , Tongue Neoplasms/diagnostic imaging
20.
Pediatr Pulmonol ; 54(11): E14-E16, 2019 11.
Article En | MEDLINE | ID: mdl-31424171

Mesenchymal hamartoma of the chest wall is a rare benign nonneoplastic lesion of infancy arising from chondro-osseous tissue. Although its natural history suggests spontaneous regression, we describe a fatal case in a neonate with significant respiratory compromise. We explored the use of electrical impedance tomography to evaluate the dynamic impact of such space occupying lesions on a ventilated infant.


Bone Diseases/diagnostic imaging , Hamartoma/diagnostic imaging , Mesenchymoma/diagnostic imaging , Thoracic Wall/diagnostic imaging , Tomography, X-Ray Computed/methods , Bone Diseases/congenital , Electric Impedance , Female , Hamartoma/congenital , Humans , Infant, Newborn , Mesenchymoma/congenital , Ribs/diagnostic imaging
...